Retinaldehyde Night Serum, graded Moderate-evidence on Magellan — several small RCTs (n = 23–40, 8–12 weeks) show objective, instrument-measured improvements in wrinkles, texture and pigmentation, with less irritation than prescription tretinoin. However, retinaldehyde-specific trials are relatively few, small and short, often industry-linked, and they measure appearance endpoints rather than systemic aging.
Source: Dermatology 1999, PMID 10473961 ↗ · Skin & Topical Longevity · How Magellan grades evidence · Study write-up · evidence confidence: high
Retinaldehyde (also called retinal or RAL) is a naturally occurring metabolite of vitamin A and the direct biosynthetic precursor of all-trans retinoic acid, the retinoid that binds nuclear retinoic-acid receptors to regulate keratinocyte proliferation and differentiation and dermal collagen metabolism. In the skin, retinaldehyde is oxidized in a single enzymatic step to retinoic acid, giving it retinoid activity with greater potency than retinol while causing less irritation than retinoic acid (tretinoin) itself. It is used in topical cosmeceutical and dermatological preparations, typically at 0.05-0.1%, to improve the appearance of photoaged skin.
Randomized controlled trials of topical retinaldehyde report improvements in fine lines, skin texture and hydration and other signs of photoaging, with tolerability better than prescription retinoic acid; in one trial a retinaldehyde cream matched a series of glycolic-acid peels on crow's-feet depth over eight weeks, and split-face testing shows objective, instrument-measured wrinkle and elasticity gains versus vehicle. Mechanistic and in vivo human studies of the broader retinoid pathway show that conversion to retinoic acid stimulates procollagen synthesis and suppresses collagen-degrading matrix metalloproteinases in aged and sun-damaged skin. However, retinaldehyde-specific trials are relatively few, small and short, often industry-linked, and they measure appearance endpoints rather than systemic aging; critical reviews caution that high-quality clinical evidence for cosmeceutical retinoids (as distinct from prescription tretinoin) remains limited. Much of the deepest mechanistic evidence derives from retinoic acid and retinol rather than from retinaldehyde directly. This evidence describes topical retinaldehyde and the retinoic-acid pathway it feeds, not this specific commercial serum product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“Retinaldehyde is efficient and well tolerated for the improvement of the signs of photoaging”
“both retinaldehyde creams afforded significant textural improvements, reduced water loss, increased hydration”
“the 3-month application significantly improved overall photoaging”
“These studies indicate that topical RAL has biological activity and is well tolerated.”
“The natural retinoids ROL and RAL do have a good tolerance profile, in contrast with the irritating potential of RA.”
“cosmeceuticals containing retinaldehyde have been shown in large randomized, controlled trials to have the most beneficial effect on aging skin.”
Research describes the active mechanism and is not a claim about this specific product.
Randomized, mostly split-face trials indicate that topical niacinamide can modestly…
Randomized and controlled human trials, together with histologic and in vitro studies,…
In a randomized community-based trial in Australia, adults assigned to daily sunscreen…
Multiple randomized and controlled clinical studies of topical HA formulations report…
Yes — its active compound is linked to 19 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.